US Tariff Deal: What It Means for UK Pharma

US tariff deal: What it means for UK pharma

Last week, the UK and US signed a zero tariff pharmaceuticals deal, but what will the deal deliver in the long term, and is all as it seems?

What the New U.S.–UK Pharmaceuticals Deal Really Means for Pricing, Access, and Global Market Dynamics

Written by: Sarah McFarlane, MSc, HealthEconomics.com The United States and United Kingdom have finalized a landmark agreement that fundamentally reshapes pharmaceutical trade, drug pricing, and market access across both nations. Marketed by the UK government as a “life sciences investment catalyst” and by the U.S. as a strategic alignment of pricing expectations, the deal eliminates tariffs on UK medicines entering the U.S. while committing the…